nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM2—Dimenhydrinate—atopic dermatitis	0.262	0.384	CbGbCtD
Scopolamine—CHRM2—Diphenhydramine—atopic dermatitis	0.128	0.187	CbGbCtD
Scopolamine—ABCB1—Tacrolimus—atopic dermatitis	0.0675	0.099	CbGbCtD
Scopolamine—ABCB1—Loratadine—atopic dermatitis	0.0494	0.0725	CbGbCtD
Scopolamine—ABCB1—Methylprednisolone—atopic dermatitis	0.0452	0.0663	CbGbCtD
Scopolamine—ABCB1—Betamethasone—atopic dermatitis	0.0294	0.0431	CbGbCtD
Scopolamine—ABCB1—Prednisolone—atopic dermatitis	0.029	0.0425	CbGbCtD
Scopolamine—ABCB1—Hydrocortisone—atopic dermatitis	0.0275	0.0403	CbGbCtD
Scopolamine—ABCB1—Prednisone—atopic dermatitis	0.0274	0.0402	CbGbCtD
Scopolamine—ABCB1—Dexamethasone—atopic dermatitis	0.0171	0.0251	CbGbCtD
Scopolamine—CHRM5—skin epidermis—atopic dermatitis	0.000564	0.368	CbGeAlD
Scopolamine—Headache—Pimecrolimus—atopic dermatitis	0.00048	0.00167	CcSEcCtD
Scopolamine—Tremor—Tacrolimus—atopic dermatitis	0.000478	0.00167	CcSEcCtD
Scopolamine—Muscular weakness—Prednisolone—atopic dermatitis	0.000478	0.00166	CcSEcCtD
Scopolamine—Irritability—Methylprednisolone—atopic dermatitis	0.000474	0.00165	CcSEcCtD
Scopolamine—Nausea—Dimenhydrinate—atopic dermatitis	0.000471	0.00164	CcSEcCtD
Scopolamine—Nausea—Diphenhydramine—atopic dermatitis	0.000471	0.00164	CcSEcCtD
Scopolamine—Agitation—Tacrolimus—atopic dermatitis	0.000469	0.00163	CcSEcCtD
Scopolamine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000469	0.00163	CcSEcCtD
Scopolamine—Muscular weakness—Hydrocortisone—atopic dermatitis	0.000467	0.00162	CcSEcCtD
Scopolamine—Vertigo—Tacrolimus—atopic dermatitis	0.000459	0.0016	CcSEcCtD
Scopolamine—Nausea—Pimecrolimus—atopic dermatitis	0.000455	0.00158	CcSEcCtD
Scopolamine—Fatigue—Mometasone—atopic dermatitis	0.000451	0.00157	CcSEcCtD
Scopolamine—Pain—Mometasone—atopic dermatitis	0.000448	0.00156	CcSEcCtD
Scopolamine—Psychotic disorder—Betamethasone—atopic dermatitis	0.000441	0.00154	CcSEcCtD
Scopolamine—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000441	0.00154	CcSEcCtD
Scopolamine—Muscular weakness—Triamcinolone—atopic dermatitis	0.000439	0.00153	CcSEcCtD
Scopolamine—Muscular weakness—Methylprednisolone—atopic dermatitis	0.000438	0.00153	CcSEcCtD
Scopolamine—Asthenia—Loratadine—atopic dermatitis	0.000438	0.00152	CcSEcCtD
Scopolamine—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000434	0.00151	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000432	0.0015	CcSEcCtD
Scopolamine—Irritability—Dexamethasone—atopic dermatitis	0.000431	0.0015	CcSEcCtD
Scopolamine—Irritability—Betamethasone—atopic dermatitis	0.000431	0.0015	CcSEcCtD
Scopolamine—Dry mouth—Tacrolimus—atopic dermatitis	0.000425	0.00148	CcSEcCtD
Scopolamine—Confusional state—Tacrolimus—atopic dermatitis	0.00042	0.00146	CcSEcCtD
Scopolamine—Amnesia—Prednisone—atopic dermatitis	0.000419	0.00146	CcSEcCtD
Scopolamine—Oedema—Tacrolimus—atopic dermatitis	0.000417	0.00145	CcSEcCtD
Scopolamine—Dry skin—Betamethasone—atopic dermatitis	0.000414	0.00144	CcSEcCtD
Scopolamine—Dry skin—Dexamethasone—atopic dermatitis	0.000414	0.00144	CcSEcCtD
Scopolamine—Body temperature increased—Mometasone—atopic dermatitis	0.000414	0.00144	CcSEcCtD
Scopolamine—Abdominal pain—Mometasone—atopic dermatitis	0.000414	0.00144	CcSEcCtD
Scopolamine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000409	0.00142	CcSEcCtD
Scopolamine—Tachycardia—Tacrolimus—atopic dermatitis	0.000407	0.00142	CcSEcCtD
Scopolamine—Conjunctivitis—Prednisolone—atopic dermatitis	0.000406	0.00141	CcSEcCtD
Scopolamine—Skin disorder—Tacrolimus—atopic dermatitis	0.000405	0.00141	CcSEcCtD
Scopolamine—Dizziness—Loratadine—atopic dermatitis	0.000404	0.0014	CcSEcCtD
Scopolamine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000403	0.0014	CcSEcCtD
Scopolamine—Muscular weakness—Dexamethasone—atopic dermatitis	0.000399	0.00139	CcSEcCtD
Scopolamine—Muscular weakness—Betamethasone—atopic dermatitis	0.000399	0.00139	CcSEcCtD
Scopolamine—Hypotension—Tacrolimus—atopic dermatitis	0.000389	0.00136	CcSEcCtD
Scopolamine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000388	0.00135	CcSEcCtD
Scopolamine—Vomiting—Loratadine—atopic dermatitis	0.000388	0.00135	CcSEcCtD
Scopolamine—Rash—Loratadine—atopic dermatitis	0.000385	0.00134	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—atopic dermatitis	0.000384	0.00134	CcSEcCtD
Scopolamine—Dermatitis—Loratadine—atopic dermatitis	0.000384	0.00134	CcSEcCtD
Scopolamine—Headache—Loratadine—atopic dermatitis	0.000382	0.00133	CcSEcCtD
Scopolamine—Bradycardia—Prednisolone—atopic dermatitis	0.000381	0.00133	CcSEcCtD
Scopolamine—Asthenia—Mometasone—atopic dermatitis	0.000376	0.00131	CcSEcCtD
Scopolamine—Irritability—Prednisone—atopic dermatitis	0.000376	0.00131	CcSEcCtD
Scopolamine—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000373	0.0013	CcSEcCtD
Scopolamine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000373	0.0013	CcSEcCtD
Scopolamine—Somnolence—Tacrolimus—atopic dermatitis	0.000371	0.00129	CcSEcCtD
Scopolamine—Pruritus—Mometasone—atopic dermatitis	0.000371	0.00129	CcSEcCtD
Scopolamine—Sweating—Methylprednisolone—atopic dermatitis	0.000367	0.00128	CcSEcCtD
Scopolamine—Hallucination—Hydrocortisone—atopic dermatitis	0.000364	0.00127	CcSEcCtD
Scopolamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000363	0.00126	CcSEcCtD
Scopolamine—Nausea—Loratadine—atopic dermatitis	0.000362	0.00126	CcSEcCtD
Scopolamine—Visual impairment—Prednisolone—atopic dermatitis	0.000361	0.00126	CcSEcCtD
Scopolamine—Dry skin—Prednisone—atopic dermatitis	0.000361	0.00126	CcSEcCtD
Scopolamine—Fatigue—Tacrolimus—atopic dermatitis	0.000359	0.00125	CcSEcCtD
Scopolamine—Constipation—Tacrolimus—atopic dermatitis	0.000356	0.00124	CcSEcCtD
Scopolamine—Pain—Tacrolimus—atopic dermatitis	0.000356	0.00124	CcSEcCtD
Scopolamine—Bradycardia—Triamcinolone—atopic dermatitis	0.000351	0.00122	CcSEcCtD
Scopolamine—Bradycardia—Methylprednisolone—atopic dermatitis	0.00035	0.00122	CcSEcCtD
Scopolamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000349	0.00121	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—atopic dermatitis	0.000347	0.00121	CcSEcCtD
Scopolamine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000346	0.0012	CcSEcCtD
Scopolamine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000345	0.0012	CcSEcCtD
Scopolamine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000344	0.0012	CcSEcCtD
Scopolamine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000343	0.0012	CcSEcCtD
Scopolamine—Hallucination—Methylprednisolone—atopic dermatitis	0.000342	0.00119	CcSEcCtD
Scopolamine—Pharyngitis—Triamcinolone—atopic dermatitis	0.000342	0.00119	CcSEcCtD
Scopolamine—Eye disorder—Hydrocortisone—atopic dermatitis	0.000342	0.00119	CcSEcCtD
Scopolamine—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000339	0.00118	CcSEcCtD
Scopolamine—Conjunctivitis—Betamethasone—atopic dermatitis	0.000339	0.00118	CcSEcCtD
Scopolamine—Arrhythmia—Prednisolone—atopic dermatitis	0.000335	0.00117	CcSEcCtD
Scopolamine—Vomiting—Mometasone—atopic dermatitis	0.000333	0.00116	CcSEcCtD
Scopolamine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000331	0.00115	CcSEcCtD
Scopolamine—Rash—Mometasone—atopic dermatitis	0.00033	0.00115	CcSEcCtD
Scopolamine—Dermatitis—Mometasone—atopic dermatitis	0.00033	0.00115	CcSEcCtD
Scopolamine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000329	0.00115	CcSEcCtD
Scopolamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000329	0.00115	CcSEcCtD
Scopolamine—Headache—Mometasone—atopic dermatitis	0.000328	0.00114	CcSEcCtD
Scopolamine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000327	0.00114	CcSEcCtD
Scopolamine—Erythema—Prednisolone—atopic dermatitis	0.000326	0.00114	CcSEcCtD
Scopolamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000326	0.00113	CcSEcCtD
Scopolamine—Eye disorder—Methylprednisolone—atopic dermatitis	0.000321	0.00112	CcSEcCtD
Scopolamine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000321	0.00112	CcSEcCtD
Scopolamine—Erythema—Hydrocortisone—atopic dermatitis	0.000319	0.00111	CcSEcCtD
Scopolamine—Bradycardia—Dexamethasone—atopic dermatitis	0.000318	0.00111	CcSEcCtD
Scopolamine—Bradycardia—Betamethasone—atopic dermatitis	0.000318	0.00111	CcSEcCtD
Scopolamine—Hallucination—Dexamethasone—atopic dermatitis	0.000311	0.00108	CcSEcCtD
Scopolamine—Hallucination—Betamethasone—atopic dermatitis	0.000311	0.00108	CcSEcCtD
Scopolamine—Nausea—Mometasone—atopic dermatitis	0.000311	0.00108	CcSEcCtD
Scopolamine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000308	0.00107	CcSEcCtD
Scopolamine—Vision blurred—Prednisolone—atopic dermatitis	0.000307	0.00107	CcSEcCtD
Scopolamine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000307	0.00107	CcSEcCtD
Scopolamine—Visual impairment—Dexamethasone—atopic dermatitis	0.000301	0.00105	CcSEcCtD
Scopolamine—Visual impairment—Betamethasone—atopic dermatitis	0.000301	0.00105	CcSEcCtD
Scopolamine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000301	0.00105	CcSEcCtD
Scopolamine—Erythema—Triamcinolone—atopic dermatitis	0.0003	0.00104	CcSEcCtD
Scopolamine—Erythema—Methylprednisolone—atopic dermatitis	0.000299	0.00104	CcSEcCtD
Scopolamine—Asthenia—Tacrolimus—atopic dermatitis	0.000299	0.00104	CcSEcCtD
Scopolamine—SI—head—atopic dermatitis	0.000295	0.193	CbGeAlD
Scopolamine—Pruritus—Tacrolimus—atopic dermatitis	0.000295	0.00103	CcSEcCtD
Scopolamine—Vertigo—Prednisolone—atopic dermatitis	0.000293	0.00102	CcSEcCtD
Scopolamine—Eye disorder—Dexamethasone—atopic dermatitis	0.000292	0.00102	CcSEcCtD
Scopolamine—Eye disorder—Betamethasone—atopic dermatitis	0.000292	0.00102	CcSEcCtD
Scopolamine—Vertigo—Hydrocortisone—atopic dermatitis	0.000286	0.000996	CcSEcCtD
Scopolamine—Arrhythmia—Betamethasone—atopic dermatitis	0.000279	0.000972	CcSEcCtD
Scopolamine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000279	0.000972	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—atopic dermatitis	0.000277	0.000965	CcSEcCtD
Scopolamine—Dizziness—Tacrolimus—atopic dermatitis	0.000276	0.00096	CcSEcCtD
Scopolamine—Erythema—Betamethasone—atopic dermatitis	0.000272	0.000948	CcSEcCtD
Scopolamine—Erythema—Dexamethasone—atopic dermatitis	0.000272	0.000948	CcSEcCtD
Scopolamine—Hallucination—Prednisone—atopic dermatitis	0.000271	0.000943	CcSEcCtD
Scopolamine—Vertigo—Triamcinolone—atopic dermatitis	0.00027	0.000938	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000269	0.000938	CcSEcCtD
Scopolamine—Vertigo—Methylprednisolone—atopic dermatitis	0.000269	0.000936	CcSEcCtD
Scopolamine—Oedema—Prednisolone—atopic dermatitis	0.000266	0.000927	CcSEcCtD
Scopolamine—Vomiting—Tacrolimus—atopic dermatitis	0.000265	0.000923	CcSEcCtD
Scopolamine—Rash—Tacrolimus—atopic dermatitis	0.000263	0.000915	CcSEcCtD
Scopolamine—Dermatitis—Tacrolimus—atopic dermatitis	0.000263	0.000914	CcSEcCtD
Scopolamine—Headache—Tacrolimus—atopic dermatitis	0.000261	0.000909	CcSEcCtD
Scopolamine—Oedema—Hydrocortisone—atopic dermatitis	0.00026	0.000905	CcSEcCtD
Scopolamine—Tachycardia—Prednisolone—atopic dermatitis	0.00026	0.000905	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000257	0.000896	CcSEcCtD
Scopolamine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000255	0.000888	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—atopic dermatitis	0.000254	0.000886	CcSEcCtD
Scopolamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000254	0.000883	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000253	0.000881	CcSEcCtD
Scopolamine—Flushing—Prednisone—atopic dermatitis	0.000253	0.00088	CcSEcCtD
Scopolamine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000253	0.000879	CcSEcCtD
Scopolamine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000251	0.000875	CcSEcCtD
Scopolamine—Dry mouth—Triamcinolone—atopic dermatitis	0.00025	0.00087	CcSEcCtD
Scopolamine—Nausea—Tacrolimus—atopic dermatitis	0.000248	0.000862	CcSEcCtD
Scopolamine—Confusional state—Methylprednisolone—atopic dermatitis	0.000246	0.000858	CcSEcCtD
Scopolamine—Oedema—Triamcinolone—atopic dermatitis	0.000245	0.000852	CcSEcCtD
Scopolamine—Vertigo—Dexamethasone—atopic dermatitis	0.000245	0.000851	CcSEcCtD
Scopolamine—Vertigo—Betamethasone—atopic dermatitis	0.000245	0.000851	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—atopic dermatitis	0.000243	0.000847	CcSEcCtD
Scopolamine—Hypotension—Hydrocortisone—atopic dermatitis	0.000243	0.000846	CcSEcCtD
Scopolamine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00024	0.000834	CcSEcCtD
Scopolamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000239	0.000832	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—atopic dermatitis	0.000239	0.000831	CcSEcCtD
Scopolamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000238	0.00083	CcSEcCtD
Scopolamine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000237	0.000826	CcSEcCtD
Scopolamine—Erythema—Prednisone—atopic dermatitis	0.000237	0.000825	CcSEcCtD
Scopolamine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000237	0.000824	CcSEcCtD
Scopolamine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000236	0.000822	CcSEcCtD
Scopolamine—Hypotension—Methylprednisolone—atopic dermatitis	0.000228	0.000795	CcSEcCtD
Scopolamine—Pain—Prednisolone—atopic dermatitis	0.000228	0.000793	CcSEcCtD
Scopolamine—Fatigue—Hydrocortisone—atopic dermatitis	0.000224	0.00078	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—atopic dermatitis	0.000223	0.000778	CcSEcCtD
Scopolamine—Pain—Hydrocortisone—atopic dermatitis	0.000222	0.000774	CcSEcCtD
Scopolamine—Oedema—Dexamethasone—atopic dermatitis	0.000222	0.000773	CcSEcCtD
Scopolamine—Oedema—Betamethasone—atopic dermatitis	0.000222	0.000773	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000219	0.000764	CcSEcCtD
Scopolamine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000218	0.000758	CcSEcCtD
Scopolamine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000218	0.000758	CcSEcCtD
Scopolamine—Agitation—Prednisone—atopic dermatitis	0.000218	0.000758	CcSEcCtD
Scopolamine—Tachycardia—Betamethasone—atopic dermatitis	0.000217	0.000755	CcSEcCtD
Scopolamine—Tachycardia—Dexamethasone—atopic dermatitis	0.000217	0.000755	CcSEcCtD
Scopolamine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000215	0.000748	CcSEcCtD
Scopolamine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000215	0.000748	CcSEcCtD
Scopolamine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000214	0.000746	CcSEcCtD
Scopolamine—Vertigo—Prednisone—atopic dermatitis	0.000213	0.000741	CcSEcCtD
Scopolamine—Fatigue—Triamcinolone—atopic dermatitis	0.000211	0.000735	CcSEcCtD
Scopolamine—Fatigue—Methylprednisolone—atopic dermatitis	0.000211	0.000733	CcSEcCtD
Scopolamine—Pain—Triamcinolone—atopic dermatitis	0.000209	0.000729	CcSEcCtD
Scopolamine—Hypotension—Dexamethasone—atopic dermatitis	0.000208	0.000723	CcSEcCtD
Scopolamine—Hypotension—Betamethasone—atopic dermatitis	0.000208	0.000723	CcSEcCtD
Scopolamine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000206	0.000716	CcSEcCtD
Scopolamine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000206	0.000716	CcSEcCtD
Scopolamine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000202	0.000702	CcSEcCtD
Scopolamine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000201	0.000701	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.0002	0.000698	CcSEcCtD
Scopolamine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000194	0.000674	CcSEcCtD
Scopolamine—Oedema—Prednisone—atopic dermatitis	0.000193	0.000674	CcSEcCtD
Scopolamine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000193	0.000672	CcSEcCtD
Scopolamine—Fatigue—Dexamethasone—atopic dermatitis	0.000192	0.000667	CcSEcCtD
Scopolamine—Fatigue—Betamethasone—atopic dermatitis	0.000192	0.000667	CcSEcCtD
Scopolamine—Pain—Dexamethasone—atopic dermatitis	0.00019	0.000661	CcSEcCtD
Scopolamine—Pain—Betamethasone—atopic dermatitis	0.00019	0.000661	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—atopic dermatitis	0.00019	0.00066	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—atopic dermatitis	0.000189	0.000657	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—atopic dermatitis	0.000188	0.000654	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000187	0.000651	CcSEcCtD
Scopolamine—Asthenia—Hydrocortisone—atopic dermatitis	0.000187	0.000649	CcSEcCtD
Scopolamine—Pruritus—Hydrocortisone—atopic dermatitis	0.000184	0.00064	CcSEcCtD
Scopolamine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000183	0.000637	CcSEcCtD
Scopolamine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000183	0.000637	CcSEcCtD
Scopolamine—Dizziness—Prednisolone—atopic dermatitis	0.000176	0.000613	CcSEcCtD
Scopolamine—Asthenia—Triamcinolone—atopic dermatitis	0.000176	0.000612	CcSEcCtD
Scopolamine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000176	0.000611	CcSEcCtD
Scopolamine—Body temperature increased—Betamethasone—atopic dermatitis	0.000176	0.000611	CcSEcCtD
Scopolamine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000176	0.000611	CcSEcCtD
Scopolamine—Abdominal pain—Betamethasone—atopic dermatitis	0.000176	0.000611	CcSEcCtD
Scopolamine—Asthenia—Methylprednisolone—atopic dermatitis	0.000175	0.00061	CcSEcCtD
Scopolamine—CHRM5—skin of body—atopic dermatitis	0.000175	0.114	CbGeAlD
Scopolamine—Pruritus—Triamcinolone—atopic dermatitis	0.000173	0.000603	CcSEcCtD
Scopolamine—Pruritus—Methylprednisolone—atopic dermatitis	0.000173	0.000602	CcSEcCtD
Scopolamine—Dizziness—Hydrocortisone—atopic dermatitis	0.000172	0.000599	CcSEcCtD
Scopolamine—Rash—Prednisolone—atopic dermatitis	0.000168	0.000584	CcSEcCtD
Scopolamine—Dermatitis—Prednisolone—atopic dermatitis	0.000168	0.000584	CcSEcCtD
Scopolamine—Fatigue—Prednisone—atopic dermatitis	0.000167	0.000581	CcSEcCtD
Scopolamine—Headache—Prednisolone—atopic dermatitis	0.000167	0.000581	CcSEcCtD
Scopolamine—Constipation—Prednisone—atopic dermatitis	0.000165	0.000576	CcSEcCtD
Scopolamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000165	0.000576	CcSEcCtD
Scopolamine—Rash—Hydrocortisone—atopic dermatitis	0.000164	0.000571	CcSEcCtD
Scopolamine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000164	0.00057	CcSEcCtD
Scopolamine—Headache—Hydrocortisone—atopic dermatitis	0.000163	0.000567	CcSEcCtD
Scopolamine—Dizziness—Triamcinolone—atopic dermatitis	0.000162	0.000564	CcSEcCtD
Scopolamine—Dizziness—Methylprednisolone—atopic dermatitis	0.000162	0.000562	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—atopic dermatitis	0.000159	0.000555	CcSEcCtD
Scopolamine—Asthenia—Betamethasone—atopic dermatitis	0.000159	0.000555	CcSEcCtD
Scopolamine—Asthenia—Dexamethasone—atopic dermatitis	0.000159	0.000555	CcSEcCtD
Scopolamine—Nausea—Prednisolone—atopic dermatitis	0.000158	0.000551	CcSEcCtD
Scopolamine—Pruritus—Dexamethasone—atopic dermatitis	0.000157	0.000547	CcSEcCtD
Scopolamine—Pruritus—Betamethasone—atopic dermatitis	0.000157	0.000547	CcSEcCtD
Scopolamine—Vomiting—Triamcinolone—atopic dermatitis	0.000156	0.000542	CcSEcCtD
Scopolamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000155	0.000541	CcSEcCtD
Scopolamine—Nausea—Hydrocortisone—atopic dermatitis	0.000154	0.000538	CcSEcCtD
Scopolamine—Rash—Triamcinolone—atopic dermatitis	0.000154	0.000537	CcSEcCtD
Scopolamine—Dermatitis—Triamcinolone—atopic dermatitis	0.000154	0.000537	CcSEcCtD
Scopolamine—Rash—Methylprednisolone—atopic dermatitis	0.000154	0.000536	CcSEcCtD
Scopolamine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000154	0.000536	CcSEcCtD
Scopolamine—Headache—Triamcinolone—atopic dermatitis	0.000153	0.000534	CcSEcCtD
Scopolamine—Headache—Methylprednisolone—atopic dermatitis	0.000153	0.000533	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—atopic dermatitis	0.000153	0.000532	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—atopic dermatitis	0.000153	0.000532	CcSEcCtD
Scopolamine—Dizziness—Dexamethasone—atopic dermatitis	0.000147	0.000511	CcSEcCtD
Scopolamine—Dizziness—Betamethasone—atopic dermatitis	0.000147	0.000511	CcSEcCtD
Scopolamine—CHRM4—head—atopic dermatitis	0.000146	0.0952	CbGeAlD
Scopolamine—Nausea—Triamcinolone—atopic dermatitis	0.000145	0.000506	CcSEcCtD
Scopolamine—Nausea—Methylprednisolone—atopic dermatitis	0.000145	0.000505	CcSEcCtD
Scopolamine—Vomiting—Dexamethasone—atopic dermatitis	0.000141	0.000492	CcSEcCtD
Scopolamine—Vomiting—Betamethasone—atopic dermatitis	0.000141	0.000492	CcSEcCtD
Scopolamine—Rash—Betamethasone—atopic dermatitis	0.00014	0.000488	CcSEcCtD
Scopolamine—Rash—Dexamethasone—atopic dermatitis	0.00014	0.000488	CcSEcCtD
Scopolamine—Dermatitis—Betamethasone—atopic dermatitis	0.00014	0.000487	CcSEcCtD
Scopolamine—Dermatitis—Dexamethasone—atopic dermatitis	0.00014	0.000487	CcSEcCtD
Scopolamine—Headache—Betamethasone—atopic dermatitis	0.000139	0.000484	CcSEcCtD
Scopolamine—Headache—Dexamethasone—atopic dermatitis	0.000139	0.000484	CcSEcCtD
Scopolamine—Asthenia—Prednisone—atopic dermatitis	0.000139	0.000483	CcSEcCtD
Scopolamine—Pruritus—Prednisone—atopic dermatitis	0.000137	0.000477	CcSEcCtD
Scopolamine—Nausea—Dexamethasone—atopic dermatitis	0.000132	0.000459	CcSEcCtD
Scopolamine—Nausea—Betamethasone—atopic dermatitis	0.000132	0.000459	CcSEcCtD
Scopolamine—Dizziness—Prednisone—atopic dermatitis	0.000128	0.000445	CcSEcCtD
Scopolamine—Vomiting—Prednisone—atopic dermatitis	0.000123	0.000428	CcSEcCtD
Scopolamine—Rash—Prednisone—atopic dermatitis	0.000122	0.000425	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—atopic dermatitis	0.000122	0.000424	CcSEcCtD
Scopolamine—Headache—Prednisone—atopic dermatitis	0.000121	0.000422	CcSEcCtD
Scopolamine—Nausea—Prednisone—atopic dermatitis	0.000115	0.0004	CcSEcCtD
Scopolamine—CHRM5—head—atopic dermatitis	0.000114	0.0744	CbGeAlD
Scopolamine—CHRM2—head—atopic dermatitis	7.82e-05	0.0511	CbGeAlD
Scopolamine—CHRM1—head—atopic dermatitis	7.12e-05	0.0465	CbGeAlD
Scopolamine—CHRM3—head—atopic dermatitis	6.37e-05	0.0416	CbGeAlD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.9e-05	0.00167	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	4.9e-05	0.00167	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.88e-05	0.00166	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	4.87e-05	0.00166	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	4.87e-05	0.00166	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.84e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	4.81e-05	0.00164	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	4.79e-05	0.00163	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	4.78e-05	0.00163	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	4.75e-05	0.00162	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	4.73e-05	0.00161	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	4.66e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	4.62e-05	0.00157	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	4.62e-05	0.00157	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	4.53e-05	0.00154	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	4.53e-05	0.00154	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	4.46e-05	0.00152	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	4.42e-05	0.00151	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	4.42e-05	0.00151	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.39e-05	0.0015	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	4.34e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	4.29e-05	0.00146	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	4.29e-05	0.00146	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	4.27e-05	0.00145	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	4.23e-05	0.00144	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	4.23e-05	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	4.21e-05	0.00143	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.21e-05	0.00143	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	4.17e-05	0.00142	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	4.15e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	4.14e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	4.13e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	4.11e-05	0.0014	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	4.09e-05	0.00139	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	4.03e-05	0.00137	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GLB1—atopic dermatitis	3.98e-05	0.00136	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	3.98e-05	0.00135	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	3.93e-05	0.00134	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.92e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	3.92e-05	0.00133	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.9e-05	0.00133	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	3.88e-05	0.00132	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	3.86e-05	0.00131	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	3.85e-05	0.00131	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	3.84e-05	0.00131	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ADSL—atopic dermatitis	3.82e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	3.8e-05	0.00129	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	3.75e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	3.75e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	3.73e-05	0.00127	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	3.72e-05	0.00127	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	3.71e-05	0.00126	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	3.68e-05	0.00125	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.68e-05	0.00125	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	3.66e-05	0.00125	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.61e-05	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	3.6e-05	0.00122	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	3.6e-05	0.00122	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.55e-05	0.00121	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	3.53e-05	0.0012	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.52e-05	0.0012	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	3.51e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	3.5e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	3.49e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	3.49e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	3.48e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	3.47e-05	0.00118	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	3.46e-05	0.00118	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	3.45e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	3.43e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	3.43e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	3.42e-05	0.00116	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	3.42e-05	0.00116	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	3.39e-05	0.00115	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	3.39e-05	0.00115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	3.38e-05	0.00115	CbGpPWpGaD
Scopolamine—SI—Disease—IL6—atopic dermatitis	3.37e-05	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.36e-05	0.00114	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	3.35e-05	0.00114	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	3.34e-05	0.00114	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	3.32e-05	0.00113	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.32e-05	0.00113	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	3.2e-05	0.00109	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.19e-05	0.00109	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	3.19e-05	0.00109	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	3.18e-05	0.00108	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	3.15e-05	0.00107	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	3.15e-05	0.00107	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	3.14e-05	0.00107	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	3.13e-05	0.00107	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	3.13e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	3.11e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.11e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	3.1e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	3.1e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	3.1e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	3.07e-05	0.00105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	3.07e-05	0.00105	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	3.06e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.05e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	3.04e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	3.02e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	3.01e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	2.99e-05	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.96e-05	0.00101	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.95e-05	0.00101	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	2.93e-05	0.000998	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.92e-05	0.000995	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	2.9e-05	0.000986	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	2.89e-05	0.000982	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.87e-05	0.000976	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	2.86e-05	0.000973	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	2.84e-05	0.000967	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	2.8e-05	0.000953	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	2.79e-05	0.00095	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	2.76e-05	0.000941	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	2.73e-05	0.000929	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	2.73e-05	0.000929	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	2.72e-05	0.000926	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.72e-05	0.000925	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.71e-05	0.000922	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.68e-05	0.000913	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	2.68e-05	0.000911	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NPS—atopic dermatitis	2.61e-05	0.000889	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	2.61e-05	0.000889	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	2.56e-05	0.000872	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	2.54e-05	0.000863	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	2.53e-05	0.000862	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	2.53e-05	0.000862	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GLB1—atopic dermatitis	2.53e-05	0.00086	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	2.52e-05	0.000859	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	2.52e-05	0.000859	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	2.5e-05	0.000851	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	2.5e-05	0.000851	CbGpPWpGaD
Scopolamine—ABCB1—head—atopic dermatitis	2.48e-05	0.0162	CbGeAlD
Scopolamine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.47e-05	0.00084	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.46e-05	0.000838	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.45e-05	0.000833	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.44e-05	0.00083	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.43e-05	0.000827	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ADSL—atopic dermatitis	2.42e-05	0.000825	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.38e-05	0.00081	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	2.37e-05	0.000808	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.37e-05	0.000807	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.35e-05	0.0008	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.34e-05	0.000797	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	2.33e-05	0.000794	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2.31e-05	0.000786	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.26e-05	0.000768	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	2.25e-05	0.000765	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.25e-05	0.000765	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.24e-05	0.000762	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	2.23e-05	0.000758	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	2.16e-05	0.000736	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.12e-05	0.000723	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	2.12e-05	0.000721	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.11e-05	0.000718	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	2.1e-05	0.000715	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	2.1e-05	0.000714	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.08e-05	0.000708	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	2.07e-05	0.000705	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.06e-05	0.000703	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	2.06e-05	0.0007	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.04e-05	0.000694	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.94e-05	0.000659	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.91e-05	0.000652	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	1.91e-05	0.00065	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.89e-05	0.000643	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.89e-05	0.000643	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	1.86e-05	0.000634	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.84e-05	0.000626	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.84e-05	0.000626	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	1.83e-05	0.000624	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	1.83e-05	0.000624	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	1.82e-05	0.000618	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	1.82e-05	0.000618	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.000616	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	1.81e-05	0.000615	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.8e-05	0.000614	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	1.8e-05	0.000612	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	1.78e-05	0.000607	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	1.78e-05	0.000606	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.75e-05	0.000596	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000589	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	1.72e-05	0.000587	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	1.72e-05	0.000584	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.71e-05	0.000582	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.7e-05	0.00058	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.69e-05	0.000575	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	1.68e-05	0.000571	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.65e-05	0.000562	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.64e-05	0.00056	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.64e-05	0.000558	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000547	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000535	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.46e-05	0.000496	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.45e-05	0.000495	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.44e-05	0.00049	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.42e-05	0.000484	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000464	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARA—atopic dermatitis	1.29e-05	0.00044	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.27e-05	0.000434	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.27e-05	0.000433	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.26e-05	0.000428	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.26e-05	0.000427	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.25e-05	0.000426	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.24e-05	0.000422	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.22e-05	0.000415	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.21e-05	0.000413	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.2e-05	0.000409	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.16e-05	0.000396	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.16e-05	0.000394	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.16e-05	0.000394	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.15e-05	0.000393	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.15e-05	0.000391	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.14e-05	0.000389	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	0.000385	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	0.000384	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.12e-05	0.00038	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.11e-05	0.000377	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.1e-05	0.000375	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.09e-05	0.000372	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.01e-05	0.000345	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	9.71e-06	0.000331	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	9.69e-06	0.00033	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	9.64e-06	0.000328	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	9.59e-06	0.000326	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	9.56e-06	0.000325	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	9.46e-06	0.000322	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	9.28e-06	0.000316	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	9.23e-06	0.000314	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	8.92e-06	0.000304	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	8.54e-06	0.000291	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARA—atopic dermatitis	8.2e-06	0.000279	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	6.84e-06	0.000233	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	6.82e-06	0.000232	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	6.75e-06	0.00023	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	6.53e-06	0.000222	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	6.51e-06	0.000222	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	6.5e-06	0.000221	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	6.48e-06	0.000221	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	6.45e-06	0.00022	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	6.42e-06	0.000218	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	6.01e-06	0.000205	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	6e-06	0.000204	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	5.94e-06	0.000202	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	5.7e-06	0.000194	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	5.45e-06	0.000186	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	3.84e-06	0.000131	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	3.83e-06	0.00013	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	3.79e-06	0.000129	CbGpPWpGaD
